Febuxostat impurity 7

• CAT Number: I014937
• CAS Number: 1350352-70-3
• Molecular Formula: C16H18N2O4S
• Molecular Weight: 334.39
• Purity: ≥95%
• Synonyms: 2-[3-[(E)-hydroxyiminomethyl]-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid
• InChI: InChI=1S/C16H18N2O4S/c1-9(2)8-22-13-5-4-11(6-12(13)7-17-21)15-18-10(3)14(23-15)16(19)20/h4-7,9,21H,8H2,1-3H3,(H,19,20)/b17-7+
• InChIKey: MDMGIABSBHFMNF-REZTVBANSA-N
• SMILES: CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)/C=N/O)C(=O)O

Febuxostat Impurity 7（Cat No.:I014937）is a process-related byproduct formed during the synthesis of febuxostat, a selective xanthine oxidase inhibitor used in the management of gout and hyperuricemia. This impurity standard is essential for pharmaceutical quality control, stability assessment, and analytical method validation, ensuring product integrity and regulatory compliance. Researchers utilize Febuxostat Impurity 7 to study drug degradation pathways, identify potential safety risks, and refine manufacturing processes. Its well-characterized structure supports accurate impurity profiling, making it an important tool in medicinal chemistry, pharmaceutical development, and regulatory research.